VA-Q-TEC has developed a new phase change material (PCM) that can be transported at -70°C without the use of dry ice.
Items such as cells and genes** using the novel PCM culture can be safely transported for up to 72 hours.
This solution reduces transportation risks and alleviates the constraints posed by dry ice.
In this way, va-q-tec is expanding its comprehensive thermal portfolio with dry-ice-free alternatives, e.g. for cell and gene trafficking.
According to Würzburg, Germany, November 28, 2023, Cells and Genes** is a medical field that is creating new standards in the fight against diseases such as cancer, Alzheimer's disease, Alzheimer's disease, and heart failure. These techniques have the potential to be the most serious of even the most serious diseases. To be successful, biopharmaceutical companies need to transport blood and cell cultures at constant low temperatures. VA-Q-TEC, a leader in thermal efficiency and temperature control** chains, is introducing a new phase change material (PCM): an innovative material that can be transported at -70°C without the use of dry ice. This innovation provides an important alternative to the company's portfolio of reusable solutions.
67g PCM is a high-performance latent heat storage material that eliminates the need for dry ice for certain transport tasks. Dry ice is solid carbon dioxide that evaporates during transportation and storage. As a result, carbon dioxide is released during its manufacture, storage, and transportation. Dry ice is also a hazardous material and is subject to air transport restrictions in addition to the necessary safety precautions during handling.
The new PCM-67G enables safe transport: According to the Convention on International Civil Aviation, this new PCM is not considered a hazardous material, it is non-toxic, non-flammable, and can be reused hundreds of times without any loss of performance. These properties make it extremely sustainable compared to dry ice. It also makes logistics planning easier: it is often not possible to supply a sufficient amount of dry ice at short notice. Instead, shippers can get cooled PCMs at any time. As a result, biopharmaceutical companies can minimize the use of dry ice unless it is unavoidable, such as for long-distance intercontinental transportation. In some cases in the clinical pharmaceutical field, it is necessary to maintain a temperature of -70°C for a long time during transportation. When used in VA-Q-proof packaging, the new -67G PCM can be stored at -60 °C for up to 72 hours.
Dr. Joachim Kuhn, CEO and Founder of VA-Q-Tec, said: "Solutions using dry ice have drawbacks. With this innovative technology, which does not require dry ice, we offer our customers and partners the possibility to choose the material that best suits their specific application. In this way, we can further limit the harmful effects and reduce the dangers of using dry ice to a certain extent. ”
*: Insulation materials and energy-saving technology.